The Covid-19 crisis has changed the outlook for companies across all industry sectors. For investors who own shares in them, the question now is whether these stocks are worth holding and where their prices will go from here.
These questions are especially important for the market's top 200 companies - which includes Croda International (LON:CRDA). These shares all have market-caps in excess of £1.0 billion and they play a vital role in the investment funds and pension portfolios of millions of savers. Indeed, the stock is currently valued at £7,447m.
So, amid the chaos of Covid-19, how has the share price responded?
Over the past 12 months, the Croda International share price has seen an absolute move of 24.6%. On a relative basis - which take into account the movement of the wider market - the shares have moved by 46.0% over the past year and by 39.3% over the past six months.
But what now?
Do analysts rate it as a buy, sell or hold?
Regardless of recent performance, the main question for investors is what the future holds. In uncertain economic conditions, it's often difficult to get an accurate view. The good news is that analysts generally understand the market's biggest businesses better than most, so they are well-placed to make predictions. That shows up in their Buy, Hold and Sell recommendations.
Among the analysts covering Croda International, there are currently:
- 1 Buy recommendations
- 14 Hold recommendations
- 0 Sell recommendations
With this kind of information, it's possible to start forming a view about the outlook for any share. A combination of recent price performance and analyst recommendations gives you a flavour of whether the market is expecting a bright future - or whether there are causes for concern.
It's also worth looking at the profile of the stock to understand whether it has strong positive exposure to important factors like Quality, Value and Momentum. On that basis, Stockopedia currently classifies Croda International as a high flyer.
Disclaimer: These articles are provided for information purposes only. The content is not intended to be a personal recommendation. The investments referred to in this article may not be suitable for all investors, and if in doubt, an investor should seek advice from a qualified investment adviser. The author has no position in the stocks mentioned, unless otherwise stated.